Ixoreal Biomed "Adopts" Ashwagandha through
the American Botanical Council

The adaptogenic herb has many traditional and modern uses

(AUSTIN, Texas, Nov. 11, 2013) The American Botanical Council (ABC) is pleased to announce that Ixoreal Biomed, an herbal extracts and pharmaceuticals company based in Los Angeles, CA, and Hyderabad, India, has adopted the highly revered traditional herb ashwagandha (Withania somnifera) through ABC’s Adopt-an-Herb Program.

Ixoreal Biomed’s three-year commitment helps ABC keep its HerbMedPro™ database up-to-date with the latest scientific and clinical research on ashwagandha. HerbMedPro is an interactive and comprehensive database available on ABC’s website that provides access to important scientific and clinical research data underlying the use of nearly 250 herbs and their effects on human health.

"ABC is deeply grateful for Ixoreal Biomed’s support, which is crucial to continuing our nonprofit educational mission," said ABC Founder and Executive Director Mark Blumenthal. "Numerous health benefits of ashwagandha have been documented for hundreds, if not thousands, of years. It is well-known in Ayurveda and other systems of traditional medicine in India. The plant’s traditional reputation as a tonic has led to a growing body of modern research. ABC is looking forward to partnering with Ixoreal Biomed to take stewardship of abstracts on current and forthcoming scientific publications on this valuable herb."

Ixoreal Biomed joins 21 additional herb- and plant-based ingredient companies that support ongoing efforts through ABC’s Adopt-an-Herb Program to collect, organize, and disseminate reliable, traditional, science-based, and clinical information on herbs, medicinal plants, and other botanical- and fungal-based ingredients. Adopt-an-Herb encourages companies and individuals to "adopt" one or more specific herbs for inclusion and ongoing maintenance in the HerbMedPro database. To date, 24 herbs have been adopted. Each adopted herb is continuously researched for new articles and studies, ensuring that its HerbMedPro record stays current and robust. The result is an unparalleled resource — not only for researchers, health professionals, industry, and consumers, but for all members of the herbal and dietary supplements community, and others — available via ABC’s information-rich website. In keeping with ABC's position as an independent nonprofit organization, herb adopters do not influence the scientific information that is compiled for their respective adopted herbs.

HerbMedPro provides online access to abstracts of scientific and clinical publications on nearly 250 commonly used medicinal herbs. Herb records in the database vary in size from those with a large amount of published data — such as Ginkgo biloba, with more than 1,000 summarized entries and links — to Acacia catechu (cutch tree or black catechu in the pea family), with fewer than 50. Each abstract also is summarized in only one sentence, thereby saving users a significant amount of time.

HerbMedPro is available to ABC members at the Academic level and higher; its "sister" site HerbMed^®, however, is free and available to the general public. HerbMed features 20-to-30 herbs from HerbMedPro that are rotated on a regular basis. Making this unique resource free to the public increases the number of people who benefit from updated information on herbs, in accordance with ABC’s nonprofit educational mission.

About Ashwagandha

Ashwagandha, a much-revered plant in traditional Ayurvedic medicine, is cultivated throughout India and much of Asia and grows to three-to-five feet tall. The root is used as an adaptogen, meaning it helps the body to cope with stress. Ashwagandha has a wide variety of traditional uses, including as a hypnotic, laxative, and tonic. In fact, the name "ashwagandha" comes from the Sanskrit word for "smells like a horse" or "horse essence," a reference to the traditional belief that the root provides the strength, character, essence, or stamina of a horse. Modern medicinal uses of ashwagandha preparations include treatment of inflammation, wasting diseases, and arthritis. Within the last few years, several clinical trials have been conducted to test the herb’s efficacy in treating infertility, tuberculosis, and anxiety, among other conditions; some trials have produced positive outcomes. In 2008, India’s Department of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homeopathy (AYUSH) chose to promote ashwagandha preparations as part of a global strategy for brand-building of Ayurvedic medicine in Western countries. Ashwagandha preparations can be found in dozens of dietary supplements and related products throughout Australia, Canada, the United States, and other countries. More information on ashwagandha can be found in this profile from HerbalGram issue 99.

About Ixoreal Biomed

Ixoreal Biomed is an herbal extracts and pharmaceuticals company based in Los Angeles, CA, and Hyderabad, India. Ixoreal is focused solely on producing a high-quality extract of ashwagandha called KSM-66®. Ixoreal has developed a proprietary process that integrates modern scientific technologies with traditional Ayurvedic concepts to produce a highly concentrated full-spectrum ashwagandha root extract. Ixoreal has invested heavily in basic research and development and in building a modern scientific repository of efficacy data on ashwagandha. To this end, Ixoreal has conducted seven human clinical trials and two animal studies on the effectiveness of ashwagandha in several important functional areas. Ixoreal describes itself as the only ashwagandha manufacturer in the world that is entirely vertically integrated with its own farms, production facilities, testing laboratories, research center, and distribution division. More information is available at www.ixoreal.com.